Build Your Comparison

Side-by-side financial analysis
ACOG logo
ACOG
SAVA logo
SAVA
Try popular comparisons:

Stock Comparison

ACOG vs SAVA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ACOG
Alpha Cognition Inc. Common Stock

Financial - Conglomerates

Financial ServicesNASDAQ • CA
Market Cap$98M
5Y Perf.-4.8%
SAVA
Cassava Sciences, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$64M
5Y Perf.-40.6%

ACOG vs SAVA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ACOG logoACOG
SAVA logoSAVA
IndustryFinancial - ConglomeratesBiotechnology
Market Cap$98M$64M
Revenue (TTM)$11M$0.00
Net Income (TTM)$-25M$-106M
Gross Margin86.4%
Operating Margin-250.1%
Total Debt$0.00$0.00
Cash & Equiv.$66M$129M

ACOG vs SAVALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ACOG
SAVA
StockNov 24Jun 26Return
Alpha Cognition Inc… (ACOG)10095.2-4.8%
Cassava Sciences, I… (SAVA)10059.4-40.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ACOG vs SAVA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ACOG leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Cassava Sciences, Inc. is the stronger pick specifically for profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇ACOG emerged as the overall leader. Track its performance:
ACOG
Alpha Cognition Inc. Common Stock
The Banking Pick

ACOG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • beta 1.29
  • -11.3% 10Y total return vs SAVA's -38.0%
  • Lower volatility, beta 1.29, current ratio 8.65x
Best for: income & stability and long-term compounding
SAVA
Cassava Sciences, Inc.
The Growth Play

SAVA is the clearest fit if your priority is growth exposure.

  • EPS growth 77.6%
  • 5.4% margin vs ACOG's -232.2%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthACOG logoACOG-116.5% NII/revenue growth vs SAVA's -5.4%
Quality / MarginsSAVA logoSAVA5.4% margin vs ACOG's -232.2%
Stability / SafetyACOG logoACOGBeta 1.29 vs SAVA's 1.92
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)ACOG logoACOG-34.4% vs SAVA's -37.7%
Efficiency (ROA)ACOG logoACOG-41.8% ROA vs SAVA's -75.3%, ROIC -32.4% vs -6.3%

ACOG vs SAVA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ACOGAlpha Cognition Inc. Common Stock
FY 2025
Service
100.0%$433,221
SAVACassava Sciences, Inc.

Segment breakdown not available.

ACOG vs SAVA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLACOGLAGGINGSAVA

Income & Cash Flow (Last 12 Months)

SAVA leads this category, winning 1 of 1 comparable metric.

ACOG and SAVA operate at a comparable scale, with $11M and $0 in trailing revenue.

MetricACOG logoACOGAlpha Cognition I…SAVA logoSAVACassava Sciences,…
RevenueTrailing 12 months$11M$0
EBITDAEarnings before interest/tax-$27M-$110M
Net IncomeAfter-tax profit-$25M-$106M
Free Cash FlowCash after capex-$30M-$84M
Gross MarginGross profit ÷ Revenue+86.4%
Operating MarginEBIT ÷ Revenue-2.5%
Net MarginNet income ÷ Revenue-2.3%
FCF MarginFCF ÷ Revenue-2.8%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-146.2%+62.1%
SAVA leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

Evenly matched — ACOG and SAVA each lead in 1 of 2 comparable metrics.
MetricACOG logoACOGAlpha Cognition I…SAVA logoSAVACassava Sciences,…
Market CapShares × price$98M$64M
Enterprise ValueMkt cap + debt − cash$32M-$65M
Trailing P/EPrice ÷ TTM EPS-5.38x-2.54x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue9.57x
Price / BookPrice ÷ Book value/share1.78x0.42x
Price / FCFMarket cap ÷ FCF
Evenly matched — ACOG and SAVA each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

ACOG leads this category, winning 5 of 6 comparable metrics.

ACOG delivers a -54.1% return on equity — every $100 of shareholder capital generates $-54 in annual profit, vs $-96 for SAVA. On the Piotroski fundamental quality scale (0–9), ACOG scores 4/9 vs SAVA's 2/9, reflecting mixed financial health.

MetricACOG logoACOGAlpha Cognition I…SAVA logoSAVACassava Sciences,…
ROE (TTM)Return on equity-54.1%-95.8%
ROA (TTM)Return on assets-41.8%-75.3%
ROICReturn on invested capital-32.4%-6.3%
ROCEReturn on capital employed-38.4%-99.9%
Piotroski ScoreFundamental quality 0–942
Debt / EquityFinancial leverage
Net DebtTotal debt minus cash-$66M-$129M
Cash & Equiv.Liquid assets$66M$129M
Total DebtShort + long-term debt$0$0
Interest CoverageEBIT ÷ Interest expense
ACOG leads this category, winning 5 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

ACOG leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in ACOG five years ago would be worth $8,873 today (with dividends reinvested), compared to $1,219 for SAVA. Over the past 12 months, ACOG leads with a -34.4% total return vs SAVA's -37.7%. The 3-year compound annual growth rate (CAGR) favors ACOG at -3.9% vs SAVA's -27.9% — a key indicator of consistent wealth creation.

MetricACOG logoACOGAlpha Cognition I…SAVA logoSAVACassava Sciences,…
YTD ReturnYear-to-date-3.1%-36.8%
1-Year ReturnPast 12 months-34.4%-37.7%
3-Year ReturnCumulative with dividends-11.3%-62.5%
5-Year ReturnCumulative with dividends-11.3%-87.8%
10-Year ReturnCumulative with dividends-11.3%-38.0%
CAGR (3Y)Annualised 3-year return-3.9%-27.9%
ACOG leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

ACOG leads this category, winning 2 of 2 comparable metrics.

ACOG is the less volatile stock with a 1.29 beta — it tends to amplify market swings less than SAVA's 1.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACOG currently trades 54.6% from its 52-week high vs SAVA's 26.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricACOG logoACOGAlpha Cognition I…SAVA logoSAVACassava Sciences,…
Beta (5Y)Sensitivity to S&P 5001.29x1.92x
52-Week HighHighest price in past year$11.54$4.98
52-Week LowLowest price in past year$4.50$1.27
% of 52W HighCurrent price vs 52-week peak+54.6%+26.5%
RSI (14)Momentum oscillator 0–10050.942.7
Avg Volume (50D)Average daily shares traded42K134K
ACOG leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ACOG as "Buy" and SAVA as "Buy".

MetricACOG logoACOGAlpha Cognition I…SAVA logoSAVACassava Sciences,…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$14.00
# AnalystsCovering analysts112
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ACOG leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). SAVA leads in 1 (Income & Cash Flow). 1 tied.

Best OverallAlpha Cognition Inc. Common… (ACOG)Leads 3 of 6 categories
Loading custom metrics...

ACOG vs SAVA: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ACOG or SAVA a better buy right now?

Analysts rate Alpha Cognition Inc.

Common Stock (ACOG) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ACOG or SAVA?

Over the past 5 years, Alpha Cognition Inc.

Common Stock (ACOG) delivered a total return of -11. 3%, compared to -87. 8% for Cassava Sciences, Inc. (SAVA). Over 10 years, the gap is even starker: ACOG returned -11. 3% versus SAVA's -38. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ACOG or SAVA?

By beta (market sensitivity over 5 years), Alpha Cognition Inc.

Common Stock (ACOG) is the lower-risk stock at 1. 29β versus Cassava Sciences, Inc. 's 1. 92β — meaning SAVA is approximately 49% more volatile than ACOG relative to the S&P 500.

04

Which is growing faster — ACOG or SAVA?

On earnings-per-share growth, the picture is similar: Cassava Sciences, Inc.

grew EPS 77. 6% year-over-year, compared to 42. 1% for Alpha Cognition Inc. Common Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ACOG or SAVA?

Cassava Sciences, Inc.

(SAVA) is the more profitable company, earning 0. 0% net margin versus -202. 2% for Alpha Cognition Inc. Common Stock — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SAVA leads at 0. 0% versus -221. 7% for ACOG. At the gross margin level — before operating expenses — ACOG leads at 81. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ACOG or SAVA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ACOG or SAVA better for a retirement portfolio?

For long-horizon retirement investors, Alpha Cognition Inc.

Common Stock (ACOG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 29)). Cassava Sciences, Inc. (SAVA) carries a higher beta of 1. 92 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACOG: -11. 3%, SAVA: -38. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ACOG and SAVA?

These companies operate in different sectors (ACOG (Financial Services) and SAVA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.